Rich Tinsley has over 20 years of life sciences consulting experience and is a recognized leader in areas of strategy, commercialization, lifecycle management and sophisticated forecast modeling. Rich has deep expertise in ACO’s and has been a speaker on the Future of Healthcare in the US.
Prior to joining RxC International, Rich was a Senior Partner at Putnam Associates and also worked for Bain & Company where he advised senior executives at 6 of the top 10 Biopharma companies and many smaller ones. Rich has worked in rare diseases, HIV, oncology, neurology, diagnostics, and many other specialty markets. Rich served as COO of a financial services company overseeing $3.6B in client assets and a CFO of a dental technology company. In both positions, Rich was responsible for setting the overall firm’s marketing strategy, optimizing its sales force investment, and managing the back office operations.
Currently, Rich serves on several boards including Massachusetts Board of Registration in Pharmacy, Sudbury Board of Education, and Diagnostyx, Inc. Rich led the expert panel on gene therapy at NYBIO 2016. His publications include several white papers and journal articles.
Rich has a B.S. in Economics and Finance from The Wharton School at University of Pennsylvania, and an M.B.A. from Stanford University Graduate School of Business.